B Verges

Summary

Affiliation: CHU de Dijon
Country: France

Publications

  1. ncbi Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome
    B Verges
    Service d endocrinologie, diabétologie et maladies métaboliques, Hopital du Bocage, CHU, Dijon, France
    Diabetes Metab 38:113-27. 2012
  2. doi Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus
    Bruno Verges
    Department of Endocrinology Diabetology, University Hospital, Dijon, France
    Arterioscler Thromb Vasc Biol 32:3050-7. 2012
  3. ncbi Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome
    B Verges
    Service d endocrinologie, diabétologie et maladies métaboliques, Hopital du Bocage, CHU, 21000 Dijon, France
    Arch Cardiovasc Dis 105:239-53. 2012
  4. ncbi Effects of glitazones in the treatment of diabetes and/or hyperlipidaemia: glycaemic control and plasma lipid levels
    Bruno Verges
    Service d endocrinologie, diabétologie et maladies métaboliques, Hopital du Bocage, C H U Dijon, France
    Fundam Clin Pharmacol 21:15-8. 2007
  5. ncbi Impact of fasting glycemia on short-term prognosis after acute myocardial infarction
    Bruno Verges
    Service d endocrinologie, Centre Hospitalier Universitaire Bocage, Bd Mal de Lattre de Tassigny, Dijon, France
    J Clin Endocrinol Metab 92:2136-40. 2007
  6. pmc Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes
    Bruno Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, Centre Hospitalier Universitaire de Dijon, 21033 Dijon, France
    J Lipid Res 50:1209-15. 2009
  7. ncbi Fenofibrate therapy and cardiovascular protection in diabetes: recommendations after FIELD
    Bruno Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, Centre Hospitalier Universitaire de Dijon, Dijon, France
    Curr Opin Lipidol 17:653-8. 2006
  8. ncbi Adiponectin is an important determinant of apoA-I catabolism
    Bruno Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, Centre Hospitalier Universitaire de Dijon, France
    Arterioscler Thromb Vasc Biol 26:1364-9. 2006
  9. ncbi New insight into the pathophysiology of lipid abnormalities in type 2 diabetes
    B Verges
    Department of Endocrinology Diabetology, University Hospital, Dijon, France
    Diabetes Metab 31:429-39. 2005
  10. ncbi Role for fibrate therapy in diabetes: evidence before FIELD
    Bruno Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, Centre Hospitalier, Universitaire de Dijon, and INSERM U498, Faculte de Medecine, Dijon, France
    Curr Opin Lipidol 16:648-51. 2005

Detail Information

Publications84

  1. ncbi Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome
    B Verges
    Service d endocrinologie, diabétologie et maladies métaboliques, Hopital du Bocage, CHU, Dijon, France
    Diabetes Metab 38:113-27. 2012
    ..Referral to a diabetologist after hospital discharge is recommended if diabetes is diagnosed by the OGTT, or during cardiac rehabilitation in cases of uncontrolled diabetes (HbA(1c)≥8%) or severe/repeated hypoglycaemia...
  2. doi Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus
    Bruno Verges
    Department of Endocrinology Diabetology, University Hospital, Dijon, France
    Arterioscler Thromb Vasc Biol 32:3050-7. 2012
    ..Plasma levels of rbp4 and triglycerides are strongly correlated in T2DM. However, we do not know whether this association is direct or indirect via liver fat content, and the link between rbp4 and triglyceride metabolism remains unknown...
  3. ncbi Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome
    B Verges
    Service d endocrinologie, diabétologie et maladies métaboliques, Hopital du Bocage, CHU, 21000 Dijon, France
    Arch Cardiovasc Dis 105:239-53. 2012
    ..Referral to a diabetologist after hospital discharge is recommended if diabetes is diagnosed by the OGTT, or during cardiac rehabilitation in cases of uncontrolled diabetes (HbA(1c) ≥ 8%) or severe/repeated hypoglycaemia...
  4. ncbi Effects of glitazones in the treatment of diabetes and/or hyperlipidaemia: glycaemic control and plasma lipid levels
    Bruno Verges
    Service d endocrinologie, diabétologie et maladies métaboliques, Hopital du Bocage, C H U Dijon, France
    Fundam Clin Pharmacol 21:15-8. 2007
    ..Rosiglitazone also increases HDL-cholesterol, but has no effect on triglycerides and increases plasma LDL-cholesterol...
  5. ncbi Impact of fasting glycemia on short-term prognosis after acute myocardial infarction
    Bruno Verges
    Service d endocrinologie, Centre Hospitalier Universitaire Bocage, Bd Mal de Lattre de Tassigny, Dijon, France
    J Clin Endocrinol Metab 92:2136-40. 2007
    ..The prognosis of patients with acute myocardial infarction (MI), according to the new criteria for impaired fasting glucose (IFG) (FG 100-126 mg/dl), has not been evaluated...
  6. pmc Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes
    Bruno Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, Centre Hospitalier Universitaire de Dijon, 21033 Dijon, France
    J Lipid Res 50:1209-15. 2009
    ..These kinetic modifications may have beneficial effects by increasing HDL plasma residence time...
  7. ncbi Fenofibrate therapy and cardiovascular protection in diabetes: recommendations after FIELD
    Bruno Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, Centre Hospitalier Universitaire de Dijon, Dijon, France
    Curr Opin Lipidol 17:653-8. 2006
    ..The purpose of this review is to analyse results from FIELD and to see whether they may lead to modify the recommendations for treatment of diabetic dyslipidemia...
  8. ncbi Adiponectin is an important determinant of apoA-I catabolism
    Bruno Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, Centre Hospitalier Universitaire de Dijon, France
    Arterioscler Thromb Vasc Biol 26:1364-9. 2006
    ....
  9. ncbi New insight into the pathophysiology of lipid abnormalities in type 2 diabetes
    B Verges
    Department of Endocrinology Diabetology, University Hospital, Dijon, France
    Diabetes Metab 31:429-39. 2005
    ..In addition, it is not excluded that adipocytokines, such as adiponectin, could play a role in the pathophysiology of lipid abnormalities in type 2 diabetes...
  10. ncbi Role for fibrate therapy in diabetes: evidence before FIELD
    Bruno Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, Centre Hospitalier, Universitaire de Dijon, and INSERM U498, Faculte de Medecine, Dijon, France
    Curr Opin Lipidol 16:648-51. 2005
    ..Statins have been shown to diminish significantly the risk for coronary disease in patients with type 2 diabetes, and so what are the real effects of fibrates on cardiovascular risk in type 2 diabetes?..
  11. ncbi High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock
    Bruno Verges
    Service d endocrinologie, Hopital du Bocage, CHU Dijon, boulevard de Lattre de Tassigny, 21034 Dijon Cedex, France
    Eur Heart J 26:1734-41. 2005
    ..No studies have yet been conducted concerning plasma N-terminal pro-brain natriuretic peptide (Nt-pro-BNP) levels after Myocardial Infarction (MI) and their relationship with short-term outcomes in diabetic patients...
  12. ncbi Diabetic dyslipidaemia: insights for optimizing patient management
    B Verges
    Service Endocrinologie Diabétologie et Maladies Métaboliques, Hopital du Bocage, Dijon, France
    Curr Med Res Opin 21:S29-40. 2005
    ..The PPARgamma agonist, pioglitazone appears to affect lipid metabolism by decreasing plasma triglycerides, increasing HDL-C and decreasing the number of small, dense atherogenic LDL particles...
  13. doi Plasma N-terminal Pro-Brain Natriuretic Peptide (Nt-proBNP) level and prognosis after myocardial infarction in diabetes
    B Verges
    Service d endocrinologie diabétologie, CHU Bocage, boulevard de Lattre de Tassigny, 21034 Dijon Cedex, France
    Diabetes Metab 34:S10-5. 2008
    ....
  14. doi Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes
    B Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, Centre Hospitalier Universitaire de Dijon, Hopital du Bocage, Dijon, BP 77908, 21079, France
    Diabetologia 51:1382-90. 2008
    ..However, its effects on the metabolism of triacylglycerol-rich lipoproteins in type 2 diabetic patients remains unknown...
  15. doi Strategies for insulin initiation: insights from the French LIGHT observational study
    Bruno Verges
    Dijon Université Hôpital, Dijon, France
    Diabetes Metab Res Rev 28:97-105. 2012
    ..The primary aim of this study was to explore insulin initiation strategies and outcomes for patients using insulin detemir or glargine plus oral anti-diabetes drugs...
  16. doi Lack of association between plasma PCSK9 and LDL-apoB100 catabolism in patients with uncontrolled type 2 diabetes
    Bruno Verges
    INSERM CRI 866, CHU Bocage, Dijon, France
    Atherosclerosis 219:342-8. 2011
    ..Here, we aimed to determine the effect of type 2 diabetes on the association between plasma PCSK9 and FCR of LDL...
  17. doi Non-ultrasound-guided ethanol sclerotherapy for the treatment of thyroid cysts
    B Verges
    Service d endocrinologie, diabétologie et maladies métaboliques, CHU de Dijon, Hopital du Bocage, France
    Ann Endocrinol (Paris) 72:203-7. 2011
    ....
  18. doi Low HDL-cholesterol: a strong predictor of glycemic response to glitazone treatment in patients with type 2 diabetes
    Bruno Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, Centre Hospitalier Universitaire de Dijon, France
    Diabetes Res Clin Pract 93:e44-8. 2011
    ..We found that low baseline HDL-cholesterol (<40 mg/L [1.04 mmol/L] in males, <50 mg/L [1.30 mmol/L] in females) was a strong independent predictor of glycemic response to glitazones (OR=2.67 [2.02-3.52], p=0.0004)...
  19. doi Combination lipid therapy in type 2 diabetes mellitus
    Bruno Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, Hopital du Bocage, Dijon, France
    Expert Opin Pharmacother 12:1393-403. 2011
    ..For this reason, combination lipid therapy may be considered in patients with type 2 diabetes...
  20. ncbi Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes
    Bruno Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, Dijon University Hospital, France
    Atherosclerosis 211:353-60. 2010
    ....
  21. doi Lipid disorders in type 1 diabetes
    B Verges
    Service d endocrinologie, de diabétologie et des maladies métaboliques, Hopital du Bocage, Dijon, France
    Diabetes Metab 35:353-60. 2009
    ..However, the precise consequences of these qualitative lipid changes on the development of cardiovascular disease in T1D are, as yet, unknown...
  22. doi Lipid modification in type 2 diabetes: the role of LDL and HDL
    Bruno Verges
    Service d endocrinologie, diabétologie et maladies métaboliques, Hopital du Bocage, CHU Dijon, France
    Fundam Clin Pharmacol 23:681-5. 2009
    ..It has been shown that HDLs from patients with type 2 diabetes have a significant reduction in their antioxidative and endothelium-dependent vasorelaxant properties...
  23. ncbi [Nutrition in patients with type 2 diabetes]
    Bruno Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, CHU Dijon, Hopital du Bocage, 21079 Dijon, France
    Rev Prat 59:54-8. 2009
    ..Moreover, an "anti-atherogenic" diet containing enough fruits, vegetables and fish should be advised in patients with type 2 diabetes...
  24. ncbi [Do the pleiotropic effects of statins have a clinical significance?]
    B Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, CHU Dijon, Hopital du Bocage, Dijon, France
    Arch Mal Coeur Vaiss 97:1231-5. 2004
    ..Finally, analysis of the results of human clinical trials on statins have proved that their effectiveness relies on the reduction in LDL-cholesterol and that the pleiotropic effects do not actually have a clinical implication...
  25. ncbi The impact of prandial glucose regulation in practice
    B Verges
    Department of Endocrinology and Diabetes, University Hospital, Dijon, France
    Diabetes Nutr Metab 15:28-32. 2002
    ..Treatment with the prandial glucose regulator repaglinide allows patients with T2DM to have a more flexible lifestyle, which is likely to improve their quality of life and compliance...
  26. ncbi Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects
    B Verges
    Service d endocrinologie, diabétologie et maladies métaboliques, CHU de Dijon, 21000 Dijon, France
    J Lipid Res 42:2021-9. 2001
    ..Plasma fasting apoA-IV is shown to be a good marker of TG response after an OFLT, providing additional information on post-load TG response in conjunction with other known factors such as fasting TGs...
  27. ncbi Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study
    Bruno Verges
    Department of Endocrinology, University Hospital, 21000 Dijon, France
    J Clin Endocrinol Metab 87:457-65. 2002
    ..Our study, based on a large group of MEN1 patients, shows that pituitary adenomas occur in 42% of the cases and are characterized by a larger size and a more aggressive presentation than without MEN1...
  28. ncbi Effects of cardiac rehabilitation on exercise capacity in Type 2 diabetic patients with coronary artery disease
    B Verges
    Department of Endocrinology Diabetology, University Hospital, Dijon, France
    Diabet Med 21:889-95. 2004
    ..To determine whether Type 2 diabetic patients with coronary disease can obtain, after cardiac rehabilitation, a similar benefit on exercise capacity to non-diabetic coronary individuals...
  29. ncbi [Statins and diabetic hyperlipidemia]
    B Verges
    Service Endocrinologie, Diabétologie et Maladies métaboliques CHU de Dijon, Hopital du Bocage, F 21000 Dijon
    Ann Endocrinol (Paris) 62:128-32. 2001
    ..But, only on going clinical trials with statins in diabetic patients will be able to precise their possible efficacy on the prevention of cardiovascular disease...
  30. ncbi Clinical interest of PPARs ligands
    B Verges
    Service d endocrinologie, diabétologie et maladies métaboliques, Hopital du Bocage, CHU de Dijon, France
    Diabetes Metab 30:7-12. 2004
    ..The potential clinical benefit of PPARs gamma agonists on the reduction of cardiovascular disease, in type 2 diabetic patients, will be specified by the ongoing intervention studies...
  31. ncbi HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study
    J M Petit
    Service d'Endocrinologie, , Dijon, France
    Horm Metab Res 32:367-72. 2000
    ..These results suggest that PI could be responsible for the development of hypertriglyceridemia by a mechanism independent of insulin resistance which remains to be elucidated...
  32. ncbi Effect of insulin treatment on plasma oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients
    F Galland
    Department of Endocrinology and Metabolic Disease, Hopital du Bocage, BP 77908, 21079 Dijon Cedex, France
    Diabetes Metab 32:625-31. 2006
    ....
  33. ncbi Normal metabolism of apolipoprotein B100-containing lipoproteins despite qualitative abnormalities in type 1 diabetic men
    L Duvillard
    INSERM U498, Bocage Hospital, BP 77908, 21079, Dijon Cedex, France
    Diabetologia 48:1366-72. 2005
    ..This stable isotope kinetic experiment was designed to study whether these abnormalities are associated with changes in the synthesis and fractional catabolic rates of VLDL-, IDL- and LDL-apoB100...
  34. doi Are elderly patients with diabetes being overtreated in French long-term-care homes?
    B Bouillet
    Service de diabétologie et endocrinologie, CHU de Dijon, Hopital du Bocage, 2, boulevard de Lattre de Tassigny, 21079 Dijon Cedex, France
    Diabetes Metab 36:272-7. 2010
    ..For this reason, the aim of the present study was to evaluate diabetes management in older, institutionalized patients...
  35. ncbi Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation
    L Persegol
    INSERM U498, Hopital du Bocage, 21079 Dijon, Cedex, France
    Diabetologia 49:1380-6. 2006
    ..In type 2 diabetic patients, HDL are glycated and more triglyceride-rich than in control subjects. These alterations are likely to modify the capacity of HDL to reverse the inhibition of vasodilation induced by oxidised LDL...
  36. ncbi Management of diabetes in French prisons: a cross-sectional study
    J M Petit
    Department of Diabetes and Endocrinology, Bocage Hospital, Dijon, France
    Diabet Med 18:47-50. 2001
    ..To assess by a survey the management of prisoners with diabetes treated with insulin in French prisons...
  37. ncbi Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus
    L Duvillard
    INSERM U 498 Métabolisme des lipoprotéines humaines et interactions vasculaires, Faculte de Medecine, 21033, Dijon, France
    Atherosclerosis 152:229-37. 2000
    ....
  38. ncbi High-density lipoprotein apolipoprotein A-I kinetics in obese insulin resistant patients. An in vivo stable isotope study
    F Pont
    Laboratoire de Biochimie des Lipoproteines, INSERM U 498, Faculte de Medecine, Dijon, France
    Int J Obes Relat Metab Disord 26:1151-8. 2002
    ....
  39. ncbi Glycemia in acute coronary syndromes
    M Zeller
    Service de cardiologie, CHU Bocage, Dijon, France
    Diabetes Metab 32:2S42-7. 2006
    ..Recent findings also argue for a direct deleterious effect of hyperglycemia on myocardium...
  40. ncbi Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C
    J M Petit
    Service de diabétologie et endocrinologie, CHU du Bocage, Dijon, France
    J Hepatol 35:279-83. 2001
    ..Our aims were to investigate the host and viral specific factors associated with diabetes mellitus (DM) and insulin resistance in chronic hepatitis C patients...
  41. doi Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes
    J M Petit
    Universite de Bourgogne, Centre de Recherche INSERM Unité 866, CHU du Bocage, BP 77908, 21079 Dijon Cedex, France
    Clin Nutr 31:520-5. 2012
    ..Although dietary fat contributes substantially to the accumulation of liver fat, the role of individual fatty acids in this accumulation is unclear...
  42. ncbi HDL particles from type 1 diabetic patients are unable to reverse the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation
    L Persegol
    INSERM Research Center 866, Dijon, France
    Diabetologia 50:2384-7. 2007
    ..Thus, we hypothesised that the ability of HDL to protect vessels against impairments of vasorelaxation would be decreased in these patients...
  43. ncbi Deleterious effect of glycation on the ability of HDL to counteract the inhibitory effect of oxidized LDL on endothelium-dependent vasorelaxation
    M C Brindisi
    INSERM Research Center 866, Dijon, France University of Burgundy, IFR100, Dijon, France Service de Diabétologie, Endocrinologie, Maladies Metabolique, CHU du Bocage, Dijon, France
    Diabetes Metab Res Rev 29:618-23. 2013
    ..The aim of this study was to analyze the role of glycation, a major abnormality observed in diabetes, on the impairment of the vasorelaxant effect of HDL...
  44. ncbi Management of hyperglycaemia in Cushing's disease: experts' proposals on the use of pasireotide
    Y Reznik
    Service Endocrinologie, CHU Cote de Nacre, 14033 Caen, France
    Diabetes Metab 39:34-41. 2013
    ....
  45. ncbi Ascorbyl free radical release in diabetic patients
    C Courderot-Masuyer
    Facultes de Medecine et de Pharmacie, Dijon, France
    Cell Mol Biol (Noisy-le-grand) 46:1397-401. 2000
    ..Uricemia was decreased in type 1 diabetic patients. Our results suggest a possible use of AFR/vitamin C ratios as indicators of oxidative stress in diabetes mellitus...
  46. ncbi Serum adiponectin and metabolic parameters in HIV-1-infected patients after substitution of nevirapine for protease inhibitors
    J M Petit
    Hopital Universitaire du Bocage, Dijon, France
    Eur J Clin Invest 34:569-75. 2004
    ..The aim of the present study was to examine whether adiponectin concentration or insulin sensitivity level correlate with the modifications of lipid parameters after the switch of PI by nevirapine...
  47. ncbi [Predictive value of glycemia in acute coronary syndromes]
    G Rioufol
    Observatoire des infarctus de la Côte d Or, Laboratoire de Physiopathologie et Pharmacologie Cardiovasculaires Experimentales, Faculte de Medecine, Dijon
    Arch Mal Coeur Vaiss 97:47-50. 2004
    ..Admission as well as follow-up glycaemia are fundamental parameters in ACS on the one hand for their prognostic value, and on the other end as a diagnostic tool in determining the presence of diabetes or IFG...
  48. ncbi [Insulin sensitiviy and lipids]
    B Verges
    Service Endocrinologie, Diabétologie et Maladies métaboliques C H U Dijon, France
    Diabetes Metab 27:223-7. 2001
    ....
  49. doi Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines
    P Goudet
    Centre Hospitalier Universitaire de Dijon, Service de Chirurgie Endocrinienne, Dijon, France
    Eur J Endocrinol 165:97-105. 2011
    ..Multiple endocrine neoplasia type 1 (MEN1) disease is an autosomal dominant syndrome that is believed to equally affect men and women. This assumption has never been confirmed...
  50. ncbi Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction
    Marianne Zeller
    Laboratory of Cardiovascular and Experimental Physiopathology and Pharmacology, Faculty of Medicine, University of Burgundy, Dijon, France
    Arch Intern Med 165:1192-8. 2005
    ....
  51. ncbi [Blood lipid abnormalities during treatment with protease inhibitors]
    B Verges
    Service Endocrinologie, diabétologie et maladies métaboliques, Hopital du Bocage, F 21034 Dijon
    Presse Med 30:911-4. 2001
    ..They could interact with the retinoid X receptor (RXR), which functions as a heterodimer with PPAR (Peroxisome Proliferator Activator Receptor). HIV-1 protease-inhibitors could also modify lipoprotein metabolism through cytokines...
  52. ncbi Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D'etude des Néoplasies Endocriniennes Multiples Study Group
    P Goudet
    Service de Chirurgie Viscerale et Urgences, Hopital General, 3 rue du Faubourg Raines, BP 1519, 21033 Dijon, France
    World J Surg 25:886-90. 2001
    ..Fifteen percent were hypocalcemic. Because MEN-I-related hHPT cure remains difficult to achieve, we advocate that subtotal parathyroidectomies be performed in specialized centers...
  53. ncbi Cardiovascular complications in type 1 diabetes mellitus
    M C Brindisi
    Service d endocrinologie diabétologie maladies métaboliques, CHU Dijon Bocage Sud, BP 77908, 21079 Dijon Cedex, France
    Diabetes Metab 36:341-4. 2010
    ....
  54. ncbi Hypercholesterolaemia in anorexia nervosa: frequency and changes during refeeding
    D Rigaud
    CESG CNRS UMR 5170, 21000 Dijon, France
    Diabetes Metab 35:57-63. 2009
    ..High total cholesterol (TC) is common in patients with anorexia nervosa (AN), but its mechanisms remain unclear...
  55. doi Outcome in AN adult patients: a 13-year follow-up in 484 patients
    D Rigaud
    Service d endocrinologie et nutrition, CHU de Dijon, 2, boulevard de Lattre de Tassigny, 21000 Dijon, France
    Diabetes Metab 37:305-11. 2011
    ..To study the long-term prognosis of anorexia nervosa (AN), 484 adult AN patients were followed on a mean duration of 13 years...
  56. ncbi LDL-receptors expression in HIV-infected patients: relations to antiretroviral therapy, hormonal status, and presence of lipodystrophy
    J M Petit
    Hopital Universitaire du Bocage, 21000 Dijon, France
    Eur J Clin Invest 32:354-9. 2002
    ..Moreover, HIV infection and HAART are associated with important modifications of hormonal status. As the cause of these adverse reactions is unknown, the effects of HAART and lipodystrophy on LDL receptors were evaluated...
  57. ncbi Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients
    Pierre Goudet
    Service de Chirurgie Endocrinienne, Centre Hospitalier Universitaire, Dijon, France
    World J Surg 34:249-55. 2010
    ..The natural history of multiple endocrine neoplasia type 1 (MEN1) is known through single-institution or single-family studies. We aimed to analyze the risk factors and causes of death in a large cohort of MEN1 patients...
  58. ncbi Distinct patterns of heparin affinity chromatography VLDL1 and VLDL2 subfractions in the different dyslipidaemias
    L Duvillard
    INSERM Research Center 866, Dijon F 21000, France
    Atherosclerosis 199:27-33. 2008
    ..g. bound VLDL2 contain the precursor pool of LDL...
  59. ncbi [The best of cardiac rehabilitation in 2006]
    B Verges
    Unité de readaptation cardiaque, centre convalescence et rééducation, 23 rue Gaffarel 21000 Dijon
    Arch Mal Coeur Vaiss 100:89-94. 2007
    ..Recommendations for participation in leisure-time physical activity and competitive sports for patients with ischaemic heart disease: the result of consensus among experts from the ESC study group of sports cardiology...
  60. doi Changes in apolipoprotein B100-containing lipoprotein metabolism due to an estrogen plus progestin oral contraceptive: a stable isotope kinetic study
    Laurence Duvillard
    Institut National de la Santé et de la Recherche Médicale Unité 866, Universite de Bourgogne, Faculte de Medecine, Dijon F 21000, France
    J Clin Endocrinol Metab 95:2140-6. 2010
    ..However, the precise changes in apoB kinetic parameters induced by oral contraceptives that are now currently used are unknown...
  61. ncbi Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen: a stable isotope kinetic study
    Jean Michel Petit
    Laboratoire de Biochimie and Institut National de la Santé et de la Recherche Médicale U498, Hopital Universitaire du Bocage, 21000 Dijon, France
    J Lipid Res 44:1692-7. 2003
    ..These data confirm that PI therapy is associated with a physiopathological mechanism for dyslipidemia in addition to the effect of lipodystrophy on lipid metabolism...
  62. ncbi Cell surface expression of LDL receptor is decreased in type 2 diabetic patients and is normalized by insulin therapy
    Laurence Duvillard
    Unity INSERM 498, Hopital du Bocage, Dijon Cedex, France
    Diabetes Care 26:1540-4. 2003
    ..This study was designed to analyze whether variations in the expression of LDL receptors at the cell surface could explain the results observed in kinetic studies...
  63. ncbi Increased apolipoprotein AI production rate and redistribution of high-density lipoprotein size induced by estrogen plus progestin as oral contraceptive
    Laurence Duvillard
    Institut National de la Santé et de la Recherche Médicale Unité 866 Université de Bourgogne, Faculte de Medecine, Dijon F 21000, France
    J Clin Endocrinol Metab 94:4891-7. 2009
    ..The impact of estrogen plus progestin as an oral contraceptive on high density lipoprotein (HDL) apolipoprotein (apo) AI metabolism in humans is poorly understood...
  64. ncbi Cell surface expression of LDL receptor in chronic hepatitis C: correlation with viral load
    Jean Michel Petit
    Service de Diabétologie et d Endocrinologie, CHU du Bocage, BP 77908, 21079 Dijon Cedex, France
    Am J Physiol Endocrinol Metab 293:E416-20. 2007
    ..In conclusion, our data provided by a human study, suggest that the LDL-R may be one of the receptors implicated in HCV replication...
  65. ncbi Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation
    Laurence Faivre
    Centre de Genetique Medicale, Hôpital d Enfants, Dijon, France
    Eur J Hum Genet 13:1186-91. 2005
    ....
  66. ncbi No change in apolipoprotein AI metabolism when subcutaneous insulin infusion is replaced by intraperitoneal insulin infusion in type 1 diabetic patients
    Laurence Duvillard
    INSERM U498, Dijon F 21000, France
    Atherosclerosis 194:342-7. 2007
    ..As far as HDL metabolism is concerned there is no advantage in favour of one way of insulin administration or another...
  67. ncbi Lack of association between microsomal triglyceride transfer protein gene polymorphism and liver steatosis in HCV-infected patients
    Jean Michel Petit
    Laboratoire INSERM Unité 498, CHU du Bocage, BP 77908, 21079 Dijon Cedex, France
    Mol Genet Metab 88:196-8. 2006
    ..The aim of our study was to investigate the influence of a functional polymorphism in the promoter region of the MTP gene (493G/T) on the development of HCV-related steatosis...
  68. ncbi Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction
    Marianne Zeller
    Service de cardiologie, CHU Bocage, Dijon, France
    Eur Heart J 25:308-12. 2004
    ..In-hospital outcome after acute myocardial infarction (MI) has not yet been evaluated with regard to the new category of Impaired Fasting Glucose level (IFG) patients defined by the American Diabetes Association (ADA)...
  69. ncbi Hormonal and psychological factors linked to the increased thermic effect of food in malnourished fasting anorexia nervosa
    Daniel Rigaud
    Service d endocrinologie et nutrition, Hôpital Centre Hospitalier Universitaire Le Bocage, 21079 Dijon Cedex, France
    J Clin Endocrinol Metab 92:1623-9. 2007
    ..Thus we investigated the thermic effect of food (TEF) in relation to subjective feelings and plasma hormone levels in a group of AN patients...
  70. ncbi Apolipoprotein-AII concentrations are associated with liver steatosis in patients with chronic hepatitis C
    Jean Michel Petit
    Laboratoire INSERM Unité 498, 21079 Dijon Cedex, France
    Dig Dis Sci 52:3431-4. 2007
    ....
  71. doi Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetes
    Jean Michel Petit
    Universite de Bourgogne, Centre de Recherche Institute National de la Santé, Dijon Cedex, France
    J Clin Endocrinol Metab 95:E430-6. 2010
    ..Recently, it has been shown in the general population that an allele in the adiponutrin (PNPLA3) gene was strongly associated with increased liver fat content (LFC), independently of visceral adiposity and insulin resistance...
  72. ncbi Comparison of apolipoprotein B100 metabolism between continuous subcutaneous and intraperitoneal insulin therapy in type 1 diabetes
    Laurence Duvillard
    Institut National de la Sante et de la Recherche Medicale, Unité 498, Hopital du Bocage, BP 77908, 21079 Dijon Cedex, France
    J Clin Endocrinol Metab 90:5761-4. 2005
    ..c. insulin infusion with i.p. insulin infusion restores the normal physiological gradient between the portal vein and the peripheral circulation, which is likely to modify lipoprotein metabolism...
  73. ncbi Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients
    Jean Michel Petit
    Service de Diabétologie et d Endocrinologie, Centre Hospitalier Universitaire du Bocage, Boite Postale 77908, 21079 Dijon Cedex, France
    J Clin Endocrinol Metab 90:2240-3. 2005
    ..We used ELISA to determine serum adiponectin, leptin, and soluble TNF receptors I and II concentrations...
  74. ncbi Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients
    Jean Michel Petit
    Centre de Recherche, Institut National de la Santé et de la Recherche Médicale Unité 866, Services de Diabétologie et Endocrinologie, Centre Hospitalier Universitaire du Bocage, 21079 Dijon Cedex, France
    J Clin Endocrinol Metab 94:4103-6. 2009
    ..In this study, we set out to determine, whether fatty liver content, evaluated using 1H-magnetic resonance spectroscopy, a very precise imaging technique, was associated with atherosclerosis in people with type 2 diabetes...
  75. ncbi [Tube feeding at home in anorexia nervosa patients]
    Daniel Rigaud
    CHU Le Bocage, service d Endocrinologie Nutrition F 21000 Dijon, France
    Presse Med 38:1739-45. 2009
    ..In the aim to explore the efficacy of tube feeding (TF) in ambulatory anorexia nervosa (AN) patients, we prospectively treated 60 AN patients by tube feeding (TF) at home, using a nasogastric tube...
  76. doi Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines)
    Pierre Goudet
    faculté de médecine de Dijon, Centre d Epidémiologie des Populations, EA4184, Universite de Bourgogne, BP 87900, 21079, Dijon Cedex, France
    World J Surg 33:1197-207. 2009
    ..The purpose of this article was to study the clinical, biological, and pathological features of Th-NET in a large cohort of patients with MEN1...
  77. doi Liver methylene fraction by dual- and triple-echo gradient-echo imaging at 3.0T: Correlation with proton MR spectroscopy and estimation of robustness after SPIO administration
    Boris Guiu
    University of Burgundy, INSERM U866, Dijon, France
    J Magn Reson Imaging 33:119-27. 2011
    ....
  78. pmc CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice
    Tony Jourdan
    Unité Mixte de Recherche 866 Institut National de la Santé et de la Recherche Médicale Université de Bourgogne, Team Physiopathology of Dyslipidemia, Faculty of Sciences Gabriel, Dijon, France
    Diabetes 59:926-34. 2010
    ..We examined the impact of CB1 antagonism on liver and adipose tissue lipid metabolism in a mouse model of diet-induced obesity...
  79. ncbi [Oral antidiabetics and lipids]
    B Verges
    Service d endocrinologie, diabétologie et maladies métaboliques, Hopital du Bocage, F 21034 Dijon cedex
    Ann Endocrinol (Paris) 63:1S45-50. 2002
    ..Thiazolidinedione (pioglitazone and rosiglitazone) effects on lipid metabolism, as well as their effects on mechanisms involved in the promotion of atherosclerosis are discussed...
  80. doi Beyond glucose lowering: glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system
    B Verges
    Department of Endocrinology and Diabetes, Bocage Hospital and Inserm CRI 866, CHU of Dijon, Dijon, France
    Diabetes Metab 37:477-88. 2011
    ..This review focuses on the potential beneficial effects of these compounds beyond those associated with improvements in blood glucose control and weight loss, including changes in the cardiovascular and central nervous systems...
  81. doi Liver carbohydrate and lipid metabolism of insulin-deficient mice is altered by trans-10, cis-12 conjugated linoleic acid
    Tony Jourdan
    Unité Mixte de Recherche 866 INSERM Université de Bourgogne, Equipe Physiopathologie des dyslipidémies, Faculte des Sciences Gabriel, 21000 Dijon, France
    J Nutr 139:1901-7. 2009
    ..The results demonstrate that t10c12CLA stimulates liver lipid accumulation in the absence of insulin and, thus, suggest that t10c12CLA can improve liver carbohydrate and lipid metabolism in type I diabetic mice...
  82. ncbi [Hypercalcemia in the elderly]
    B Verges
    Service d endocrinologie, diabétologie et maladies métaboliques, Hopital du Bocage, F 21000 Dijon
    Presse Med 30:313-6. 2001
    ..Symptoms due to hypercalcemia are usually non specific in old subjects, leading to consider easily this diagnosis and to measure plasma calcium level...
  83. ncbi [Does thyroidectomy worsen Graves'ophtalmopathy?]
    M Claret-Gardette
    Service d Endocrinologie et Maladies Métaboliques, Hopital du Bocage, CHU de Dijon, 3, rue du Faubourg Raines, 21000, Dijon, France
    Ann Chir 128:88-93. 2003
    ..To determine if thyroïd surgery increase or not the eye symptoms in patients with Graves'ophtalmopathy...
  84. pmc Apolipoprotein CI is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma
    Jean Paul Pais de Barros
    INSERM, Centre de Recherche Unite Mixte de Recherche 866, Faculte de Medecine, Universite de Bourgogne, 21079 Dijon, France
    J Lipid Res 50:1842-51. 2009
    ..In contrast, CETP is the sole major determinant of cholesteryl ester transfer in normolipidemic rabbit plasma as a result of the inability of rabbit apoCI to change HDL electronegativity...